These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 25536893)
1. [Pharmacovigilance in child and adolescent psychiatry]. Egberts K; Karwautz A; Plener PL; Mehler-Wex C; Kölch M; Dang SY; Taurines R; Romanos M; Gerlach M Z Kinder Jugendpsychiatr Psychother; 2015 Jan; 43(1):21-8. PubMed ID: 25536893 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic drug monitoring as a measure of proactive pharmacovigilance in child and adolescent psychiatry. Gerlach M; Egberts K; Dang SY; Plener P; Taurines R; Mehler-Wex C; Romanos M Expert Opin Drug Saf; 2016 Nov; 15(11):1477-1482. PubMed ID: 27551945 [TBL] [Abstract][Full Text] [Related]
3. [Therapeutic drug monitoring to optimize psychopharmacotherapy in children and adolescents - Update and guidelines for practice]. Egberts K; Fekete S; Häge A; Hiemke C; Scherf-Clavel M; Taurines R; Unterecker S; Gerlach M; Romanos M Z Kinder Jugendpsychiatr Psychother; 2021 Mar; 50(2):133-152. PubMed ID: 35274573 [TBL] [Abstract][Full Text] [Related]
4. [Reports. The psychopharmacological off-label prescribing in the treatment of children and adolescents with psychiatric disorders]. Oehler KU; Romanos M; Uzelli-Schwarz O; Dieffenbach R; Vulturius G; Holtmann M; Wewetzer C Z Kinder Jugendpsychiatr Psychother; 2016; 44(4):315-7. PubMed ID: 27434690 [No Abstract] [Full Text] [Related]
5. [The Pharmacological Management of Emergencies in Child and Adolescent Psychiatry]. Vloet TD; Fekete S; Gerlach M; Romanos M Z Kinder Jugendpsychiatr Psychother; 2022 Jul; 50(4):262-274. PubMed ID: 34668770 [TBL] [Abstract][Full Text] [Related]
7. [Polypharmacy of psychotropic drugs in child and adolescent psychiatry in Germany - rather the rule than the exception]. Vloet TD; Egberts K; Taurines R; Wewetzer C; Mehler-Wex C; Plener PL; Romanos M; Gerlach M Z Kinder Jugendpsychiatr Psychother; 2019 May; 47(3):193-202. PubMed ID: 30422047 [TBL] [Abstract][Full Text] [Related]
8. Psychotropic drug concentrations and clinical outcomes in children and adolescents: a systematic review. Kloosterboer SM; Vierhout D; Stojanova J; Egberts KM; Gerlach M; Dieleman GC; Hillegers MHJ; Passe KM; Gelder TV; Dierckx B; Koch BCP Expert Opin Drug Saf; 2020 Jul; 19(7):873-890. PubMed ID: 32421365 [TBL] [Abstract][Full Text] [Related]
9. [Particularities and problems of psychopharmacology in childhood and adolescence]. Gerlach M; Renner T; Romanos M Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Jul; 66(7):761-766. PubMed ID: 37277511 [TBL] [Abstract][Full Text] [Related]
11. [Drug therapy in child and adolescent psychiatry in Germany between ethical as well as social and legal conflicts]. Gerlach M; Warnke A Z Kinder Jugendpsychiatr Psychother; 2016; 44(4):249-55. PubMed ID: 27434686 [No Abstract] [Full Text] [Related]
12. A Critical Commentary on the 2017 AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology. de Leon J Pharmacopsychiatry; 2018 Jan; 51(1-02):63-68. PubMed ID: 28922669 [TBL] [Abstract][Full Text] [Related]
13. Design and methods of the 'monitoring outcomes of psychiatric pharmacotherapy' (MOPHAR) monitoring program - a study protocol. Simoons M; Ruhé HG; van Roon EN; Schoevers RA; Bruggeman R; Cath DC; Muis D; Arends J; Doornbos B; Mulder H BMC Health Serv Res; 2019 Feb; 19(1):125. PubMed ID: 30764821 [TBL] [Abstract][Full Text] [Related]
14. [The new German drug market law AMNOG from a child and adolescent psychiatry perspective]. Dittmann RW Nervenarzt; 2016 Apr; 87(4):367-75. PubMed ID: 26992908 [TBL] [Abstract][Full Text] [Related]
15. Sense and Sensibility When Prescribing 'Off-Label' to Psychiatric Patients. Baldwin DS; Tiwari N; Gordon R Curr Pharm Des; 2015; 21(23):3276-9. PubMed ID: 26088118 [TBL] [Abstract][Full Text] [Related]
16. Editorial: Off-label Treatments for Mental Health: Inappropriate or Unavoidable? A Special Issue to Help Get Through the Maze. Rolland B; Amad A Curr Pharm Des; 2015; 21(23):3274-5. PubMed ID: 26238988 [No Abstract] [Full Text] [Related]
17. Personalized prescribing: a new medical model for clinical implementation of psychotropic drugs. Eap CB Dialogues Clin Neurosci; 2016 Sep; 18(3):313-322. PubMed ID: 27757065 [TBL] [Abstract][Full Text] [Related]
18. [Safety of psychopharmacotherapy: a clinical and pharmacological approach]. Kirilochev OO; Umerova AR Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10):127-133. PubMed ID: 31793554 [TBL] [Abstract][Full Text] [Related]
19. Learning the effects of psychotropic drugs during pregnancy using real-world safety data: a paradigm shift toward modern pharmacovigilance. Lupattelli A; Spigset O; Nordeng H Int J Clin Pharm; 2018 Aug; 40(4):783-786. PubMed ID: 29948744 [TBL] [Abstract][Full Text] [Related]
20. Value of a web-based pediatric drug information system to prevent serious adverse drug reactions in child and adolescent psychiatry. Fekete S; Kulpok C; Taurines R; Egberts K; Geissler J; Gerlach M; Malonga Makosi D; König J; Urschitz MS; Toni I; Neubert A; Romanos M J Neural Transm (Vienna); 2023 Jan; 130(1):53-63. PubMed ID: 36324035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]